![]() |
市場調查報告書
商品編碼
1858593
全球二甲基亞碸市場趨勢、應用與預測分析Dimethyl Sulfoxide Market, Trends, Applications and Forecast Analysis |
||||||
二甲基亞碸的需求量
從應用領域來看,製藥業是二甲基亞碸(DMSO)的最大消費產業,其用途廣泛,涵蓋藥物載體和冷凍保護劑等。 DMSO 具有抗發炎、鎮痛、抗菌、抗真菌和抗病毒特性,使其作為藥物中間體廣泛應用。 DMSO 能夠以最小的組織損傷穿透人體皮膚,因此被應用於經皮給藥系統,為止痛藥和類固醇等藥物的給藥提供了一種有效途徑。 DMSO 也獲準用於治療膀胱疼痛症候群,並用於幹細胞和骨髓保存。
在農業化學品領域,二甲基亞碸(DMSO)用作除草劑和殺蟲劑合成的反應介質,有助於提高吸收率和製劑穩定性。 DMSO 也可用於加速土壤反應並提高農藥的藥效。此外,DMSO 也應用於聚合物加工、清潔劑和脫漆劑等領域,其優異的溶解性能使其能夠溶解多種樹脂、塗料和有機基材。
二甲基亞碸區域需求分析
亞太地區引領全球二甲基亞碸(DMSO)市場,這主要得益於中國、印度和韓國等國強大的製藥生產基礎設施以及活性化的農業活動。區域政府對醫療保健擴張的支持、活性藥物成分(API)的在地化生產以及對作物保護解決方案不斷成長的投資,都在推動市場需求。北美地區憑藉其發達的製藥行業以及對經皮吸收貼片先進給藥系統的日益依賴,仍然是領先的市場。在美國,監管核准和臨床研究的進展正在推動DMSO在製劑和臨床實驗藥物中的應用。
在西歐,嚴格的環境法規推動工業和製藥領域使用環保和可生物分解溶劑,刺激了市場需求。在拉丁美洲和中東及非洲等新興經濟體,不斷擴大的農業化學品市場和不斷完善的醫療基礎設施正逐步提升二甲基亞碸(DMSO)的消費量,為預測期內的良好成長奠定了基礎。
主要製造商
主要生產商包括蓋洛德化學公司、阿科瑪公司、湖北興發化學Group Limited和東麗精細化學公司。
市場促進因素:製藥業的成長
DMSO市場的主要成長動力在於其在製藥業日益廣泛的應用。全球對健康和治療方法創新的關注度不斷提高,尤其是在新冠疫情之後。隨著對更有效、更微創的藥物遞送系統的需求不斷成長,DMSO作為一種可滲透皮膚的溶劑的作用也愈發重要。此外,幹細胞和再生醫學的復興也推動了其作為冷凍保護劑的應用。
在農業化學品領域,提高農業生產力和減少化學品徑流的壓力日益增大,促使人們採用高效載體,例如二甲基亞碸(DMSO),它可以提高農藥的溶解度和藥效。 DMSO 能夠提高反應速率並促進其有效滲入土壤,使其成為永續農業中備受重視的投入物。在工業應用領域,對環保溶劑的需求不斷成長,尤其是在塗料和清潔劑領域,這推動了市場對 DMSO 的需求。
市場限制因素:監理制約因素
二甲基亞碸( DMSO)市場面臨一些限制因素。圍繞DMSO醫療用途的監管不確定性限制了其在一些國家的廣泛應用。儘管美國FDA已核准其用於有限的醫療用途,但由於對其潛在副作用的核准以及缺乏針對特定用途的廣泛臨床試驗,DMSO在世界許多地區仍未獲準用於醫療用途或受到限制。
本報告分析了全球二甲基亞碸市場,並提供了市場動態和行業趨勢、各細分市場的需求預測以及製造商概況等資訊。
Dimethyl Sulfoxide
Dimethyl sulfoxide (DMSO) is a colorless, organosulfur compound extensively utilized across various industries, particularly pharmaceuticals and agrochemicals. Derived primarily as a by-product of the Kraft pulping process through oxidation of dimethyl sulfide, DMSO has gained prominence as a biodegradable, non-toxic solvent that replaces more hazardous chemical counterparts. Its high polarity, aprotic characteristics, and ability to dissolve both polar and non-polar compounds make it indispensable in numerous formulations. DMSO has evolved from a specialty solvent to a vital pharmaceutical intermediate with increasing relevance in modern medicine and crop protection systems due to its therapeutic properties and ability to enhance cellular membrane penetration.
Dimethyl Sulfoxide Demand, by Application
Based on application segments, the pharmaceutical industry represents the largest consumer base for DMSO, driven by its multifaceted roles ranging from a drug carrier to a cryoprotectant. DMSO's anti-inflammatory, analgesic, antibacterial, antifungal, and antiviral properties underpin its widespread application as a pharmaceutical intermediate. The compound is employed in transdermal drug delivery systems due to its ability to penetrate human skin with minimal tissue disruption, offering an effective route for administering medications such as pain relief formulations and steroids. DMSO is also approved for treating bladder pain syndrome and is used in preserving stem cells and bone marrow.
In agrochemicals, DMSO serves as a reaction medium for synthesizing herbicides and insecticides, aiding in enhanced absorption and improved formulation stability. It is employed to accelerate soil reaction kinetics and improve agrochemical efficacy. Other applications include its use in cleaning solutions, paint stripping, and polymer processing leveraging DMSO's excellent solvency power to dissolve a broad range of resins, coatings, and organic substrates.
Dimethyl Sulfoxide Regional Demand Analysis
Asia Pacific leads the global DMSO market, attributed to robust pharmaceutical manufacturing infrastructure and increasing agricultural activities in countries such as China, India, and South Korea. The demand is reinforced by regional government support for healthcare expansion, local production of active pharmaceutical ingredients (APIs), and growing investments in crop protection solutions. North America follows as a key market, with a well-established pharmaceutical sector and an increasing reliance on advanced drug delivery systems, such as transdermal patches. Regulatory approval and clinical research initiatives in the U.S. drive the uptake of DMSO in drug formulations and investigational therapies.
In Western Europe, the demand is propelled by strict environmental regulations promoting the use of eco-friendly and biodegradable solvents in industrial and pharmaceutical applications. Emerging economies in Latin America and the Middle East & Africa are witnessing a gradual rise in DMSO consumption due to expanding agrochemical markets and improving healthcare infrastructure, offering promising growth avenues during the forecast period.
Key Manufacturers
Prominent players include Gaylord Chemical Corporation, Arkema, Hubei Xingfa Chemicals Group Co., Ltd., Toray Fine Chemicals.
Market Driver: Growing pharmaceutical industry
The primary growth driver for the DMSO market is its expanding application in the pharmaceutical industry, especially after the COVID-19 pandemic, which heightened global awareness regarding health and therapeutic innovations. As demand for more effective, less invasive drug delivery systems increases, DMSO's role as a skin-penetrating solvent becomes more vital. The resurgence in stem cell and regenerative medicine has also bolstered its application as a cryoprotective agent.
In agrochemicals, growing pressure to increase agricultural productivity and reduce chemical runoff is encouraging the adoption of highly efficient carriers like DMSO, which enhance agrochemical solubility and performance. The compound's ability to improve reaction rates and facilitate effective soil integration makes it a valued input in sustainable agriculture. The shift toward environmentally benign solvents in industrial applications supports its demand, especially in coatings and cleaning agents.
Market Restraint: Regulatory restrictions
Dimethyl sulfoxide market faces certain constraints. Regulatory uncertainty in some countries surrounding the medical application of DMSO restricts its full-scale adoption. While the U.S. FDA has approved limited pharmaceutical use, DMSO remains unapproved or controlled for medicinal purposes in many global regions due to concerns over its potential side effects and lack of large-scale clinical trials in certain use cases.
Note: Demand Analysis has been provided for all major Regions / Countries as mentioned below. The demand (consumption) split by applications have been provided for each of the countries / regions in Volume (Kilo tons) and Value (USD Million).
Note: CAGR will be calculated for all applications to arrive at the regional / global demand growth for the forecast period (2025 - 2034)
Note: This section includes company information, company financials, manufacturing bases and operating regions. Company financials have been mentioned only for those companies where financials were available in SEC Filings, annual reports, or company websites. All the reported financials in this report are in U.S. Dollars. Financials reported in other currencies have been converted using average currency conversion rates. Company profiles may include manufacturers, suppliers, and distributors.